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Introduction
Quinolones and fluoroquinolones (FQ) are broad-spectrum
antimicrobial compounds and of critical importance in clinical use.
They are the antimicrobials of choice in the treatment of acute
gastrointestinal infections, urinary tract infections and respiratory
tract infection. Resistance to FQ drugs increased in past years
following the extensive and widespread use.
The mechanisms of action of (F)Qs is due to inhibition of DNA
replication and resistance to (F)Qs is either based on (i) mutational
alterations in the FQ target enzymes: DNA topoisomerase II (DNA
gyrase) and topoisomerase IV, or (ii) plasmid-mediated quinolone
resistance (PMQR) mechanisms or simply (iii) the decreased uptake
of the drug due to the loss of a membrane-bound porin and/or drug
extrusion via efflux pumps [1,2]. PMQR mechanisms include target
protection proteins of the qnr gene family, enzymatic modification
gene aac-(69)-Ib-cr and the efflux pump gene qepA. So far, five
different qnr genes with a number of variations have been described:
qnrA, qnrB, qnrC, qnrD and qnrS [3–7]. The Qnr proteins belong to the
pentapeptide family of proteins and share common structural
properties. AAC(69)-Ib-cr differs from the aminoglycoside acetyl-
transferase, AAC(69)-Ib, by two specific codon exchanges
Trp102RArg and Asp179RTyr, which have been found to be
necessary and sufficient for the ciprofloxacin (CIP) resistance
phenotype [8]. The PMQR mechanisms confer only low level
resistance to quinolones and thus, they were thought to enable the
occurrence of chromosomal mutation which then lead to clinically
relevant resistance levels [9].
In a previous study [10], 42 of 60 extended-spectrum b-
lactamase-producing Escherichia coli strains isolated from rivers and
lakes additionally displayed increased levels of nalidixic acid (NA)
and/or CIP resistance.
The spread of E. coli co-expressing (fluoro)quinolone resistance
along with extended-spectrum b-lactamases into the environment,
especially into water bodies such as rivers, streams, wastewater
effluents and lakes is worrisome. Rivers are considered to be of
special importance as a reservoir of resistance genes since they are
recipients of bacteria from different sources, e.g., wastewater plants,
water of urban or industrial effluents, or agricultural activities [11].
The aim of this study was to identify and characterize quinolone and
fluoroquinolone resistance mechanisms in higher generation cephalo-
sporin resistant E. coli isolated from rivers and lakes in Switzerland.
Materials and Methods
Bacterial Isolates
Forty-two of 60 extended-spectrum b-lactamase-producing
Escherichia coli strains isolated from rivers and lakes during a
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previous study and additionally displaying increased levels of
nalidixic acid (NA) and/or CIP resistance were selected for this
study. The protocol for collecting the water samples and isolating
the strains as well as the species identification, antibiotic sensitivity
testing and the characterization of the ESBL-types were described
in the previous study [10].
MIC Determination of Nalidixic Acid and Ciprofloxacin
MICs for NA and CIP of all 42 strains were determined using
Etest strips (bioMe´rieux, Marcy l’Etoile, France). Of selected
strains, MICs for NA (Sigma-Aldrich, Switzerland) were deter-
mined by the broth microdilution method according the Clinical
and Laboratory Standards Institute (CLSI) [12], in the absence
and presence of 40 mg/ml phe-arg-b-naphthylamide (PAbN)
(Sigma-Aldrich, Switzerland). As recommended by the CLSI,
the E. coli ATCC25922 was included as quality control strain.
Identification of Quinolone Resistance Determinants and
DNA Sequencing
DNA was extracted by a standard heat lysis protocol.
Amplification of the quinolone resistance-determining regions
(QRDRs) of the gyrA, gyrB, parC and parE genes and PCR based
detection of the plasmid-mediated quinolone resistance (PMQR)
markers (qnrA, qnrB, qnrC, qnrD, qnrS, aac(69)-Ib-cr and qepA) was
performed using primers listed in Table 1. Custom-sequencing was
performed by Microsynth (Balgach, Switzerland) and the nucle-
otide and translated protein sequences were analyzed with CLC
Main Workbench 6.6.1. For database searches the BLASTN and
BLASTP programs of NCBI (http://www.ncbi.nlm.nih.gov/
blast/) were used.
Transferability of the PMQR Determinants
Conjugation experiments were performed with the plasmid-free
recipient strain E. coli HK225 strain (Strepr, Rifr) [13] in order to
assess the transferability of the plasmid-mediated quinolone
resistance markers qnrS1, aac-69-Ib-cr and qepA. Four qnrS1
(OW1E2, OW54E2, OW60E1 and OW95E1), five aac-69-Ib-cr
(OW8C2, OW29E1; OW55C1, OW77E1 and OW89E1) and one
qepA (OW54E1) positive isolates were selected at random as
putative conjugation donors. Briefly, single colonies of the donor
and recipient were inoculated in LB broth (Difco Laboratories)
and grown overnight at 37uC. Subsequently, equal volumes of the
donor and recipient cultures were mixed and incubated overnight
at 37uC without shaking. Serial dilutions were then plated on LB
agar (Difco Laboratories) selection plates supplemented with a
combination of 600 mg/ml streptomycin (Sigma-Aldrich, Switzer-
land), 100 mg/ml rifampicin (Sigma-Aldrich, Switzerland) and
either 10 mg/ml cefotaxime (Sigma-Aldrich, Switzerland) or
20 mg/ml tetracycline (Sigma-Aldrich, Switzerland). The colonies
from the selection plates were examined by pulsed field gel
Table 1. Target genes, primers and PCR reaction conditions used for strain characterization.
Target Primer Sequence (59-39) Annealing temperature (6C) Product size (bp) Reference
Detection primers
qnrA QnrAm-F AGAGGATTTCTCACGCCAGG 54 516 [39]
qnrA_R GCCATACCTACGGCGATACC [40]
qnrB qnrB_F GATCGTGAAAGCCAGAAAGG 54 476 [41]
qnrB_R ATGAGCAACGATGCCTGGTA [41]
qnrC qnrC-F GGGTTGTACATTTATTGAATC 47 447 [6]
qnrC-R TCCACTTTACGAGGTTCT [6]
qnrD qnrD fw CGAGATCAATTTACGGGGAATA 54 582 [7]
qnrD rev AACAAGCTGAAGCGCCTG [7]
qnrS QnrSm-F GCAAGTTCATTGAACAGGGT 54 428 [39]
QnrSm-R TCTAAACCGTCGAGTTCGGCG [39]
aac(69)-Ib-cr aac(69)-Ib_For TTGCGATGCTCTATGAGTGGCTA 55 482 [42]
aac(69)-Ib_Rev CTCGAATGCCTGGCGTGTTT [42]
qepA QEPfor TGGTCTACGCCATGGACCTCA 56 1137 [43]
QEPrev TGAATTCGGACACCGTCTCCG [43]
Sequencing primers
gyrA gyrA WF AAATCTGCCCGTGTCGTTGGT 55 344 [41]
gyrA WR GCCATACCTACGGCGATACC [41]
gyrB gyrB-F GAAATGACC CGCCGTAAA 55 272 [44]
gyrB-R ACGACCGATACCACAGCC [44]
parC parC WF CTGAATGCCAGCGCCAAATT 55 168 [41]
parC WR GCGAACGATTTCGGATCGTC [41]
parE parE-F CTGAACTGCTGGCGGAGATG 60 483 [44]
parE-R GCGGTGGCAGTGCGACGTAA [44]
qnrS qnrS1_orf_f GTTGTAATGTGTTGATGTAACAGG 52 825 This study
qnrS1_orf_r CCCTATGTCTATTATTGCAAGG This study
doi:10.1371/journal.pone.0095864.t001
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electrophoresis (PFGE) to ensure acquisition of the plasmid. PCR
was performed to (i) identify the resistance genes acquired by the
transconjugants and (ii) for replicon typing the plasmids harboring
PMQR genes co-transferred to the transconjugants.
Replicon Typing
Plasmids were assigned to incompatibility groups on the basis of
the presence of specific replicon sequences identified by PCR [14].
Results
Of the total of 60 ESBL-producing E. coli isolates, 42 co-
expressing (F)Q resistance were further characterized. Based on
the Etest assay, two strains showed intermediate resistance to NA,
nine were classified as resistant to NA, two were resistant to NA
and showed intermediate resistance to CIP and 29 were resistant
to NA and CIP.
In 40/42 (95.2%) of the investigated isolates, at least one point
mutation leading to amino acid substitution in any of the
quinolone resistance-determining regions (QRDR) of gyrA, parC
and parE was detected (Table 2). No mutations were identified in
gyrB. High-level resistance to NA was always attributed to a single
mutation in gyrA, whereas strains resistant to both tested (F)Qs
exhibited at least one point mutation in two different topoisom-
erase genes; most frequently in gyrA and parC. A total of ten strains
showed only one point mutation, nine had the predominate
substitution in GyrA Ser83RLeu and one a Ser83RVal
exchange. One strain (OW55E1) showed one substitution in
GyrA (Ser83RLeu) and one in ParC (Ser80RArg). Six strains had
the following set of substitutions: GyrA (Ser83RLeu and
Asp87RAsn), and ParC (Ser80RIle). OW86E2 showed the same
substitutions in GyrA, but in ParC (Glu84RVal). Twenty-one
strains showed four substitutions in at least two different proteins:
fourteen had substitutions in GyrA (Ser83RLeu, Asp87RAsn) in
ParC (Ser80RIle) and in ParE (Ser458R Ala), five strains in GyrA
(Ser83RLeu, Asp87RAsn) in ParC (Ser80RIle, Glu84RVal),
OW54E1 in GyrA (Ser83RLeu, Asp87RAsn) in ParC (Ser80-
RIle, Glu84RGly) and OW60C2 in GyrA (Ser83RLeu,
Asp87RAsn) in ParC (Ser80RIIe) and ParE (Glu460RAsp),
respectively. Strain OW1C2 exhibited unique substitutions in
GyrA: besides the frequently substituted position Ser83, here
(Ser83RTre), also positions Ile112RVal, Leu127RMet, Ala128R
Ser and Lys154RArg were affected. Additionally, substitutions in
ParC (Ser80RIle) and in ParE (Ser458R Ala) were detected.
Twenty isolates (48%) harbored plasmid-mediated quinolone
resistance (PMQR) genes. Most frequently the aac-69-Ib-cr gene
15/42 (36%) was found, followed by qnrS1 4/42 (10%) and qepA 1/
42 (2%). The qnrA, qnrB, qnrC and qnrD genes were not detected in
this study.
Intermediate resistance to NA was associated either with the
presence of the plasmid-mediated resistance protein QnrS1 since
in two strains (OW54E2 and OW60E1) chromosomal mutations
and other PMQR determinants were absent, or with the presence
of general efflux pumps.
Conjugation experiments revealed that two of the four qnrS1,
three of five selected aac-69-Ib-cr but not the qepA bearing plasmid
were transferable to the recipient strain E. coli HK225.
Plasmid incompatibility typing of the transconjugants revealed
that both the qnrS1 and aac-69-Ib-cr genes were present on IncF
plasmids. Furthermore, all transferred PMQR determinants were
detected on the same plasmids as the blaESBL genes. The
contribution to FQ resistance of the plasmids bearing the PMQR
determinates was measured by the difference in the MICs (NA and
CIP) of the recipient strain (E. coli HK225) compared to the
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transconjugants. The effect on the resistance to NA was minimal
since the MICs increased only 1-3-fold. However, the resistance to
CIP increased by factors of 4 to 16 in the presence of PMQR
determinant harboring plasmids (Table 3).
In the presence of the efflux pump inhibitor PAbN, the MICs of
NA decreased 4 to 32-fold. This finding confirmed that also efflux
pump activity is involved in quinolone resistance (Table 4).
Discussion
So far, there are only few studies that have investigated the
occurrence of (fluoro)quinolone resistant Enterobacteriaceae in surface
waters [15–18]. Rivers and lakes are known to be a relevant
putative reservoir of multiresistant bacteria since they collect
surface waters containing material from different origins, e.g.,
wastewater plants, water from urban or industrial effluents,
agricultural activities, and they harbor an immense antibiotic
resistome, distributed to pathogenic and nonpathogenic bacteria
[19].
FQ resistance in E. coli is associated predominantly with DNA
topoisomerase II (DNA gyrase) and topoisomerase IV involving
specific mutations in the QRDRs of gyrA and parC genes [2]. A
single mutation in the QRDR of gyrA seems to be sufficient to
generate a high-level quinolone, and a double mutation even a
high-level fluoroquinolone resistance phenotype [20]. It is
supposed that these mutations occur in a stepwise manner [2].
The effect of these mutations may alter the formation of hydrogen
bonds, and the negative charge of the amino acids seem to be
important for quinolone interactions with the DNA-gyrase-DNA
complex [21].
As in previous studies, we mainly detected the substitutions in
terms of amino acid positions GyrA Ser83RLeu and GyrA
Asp87RAsn, which are located within the QRDR. Interestingly,
OW1C2, besides harboring a substitution at position GyrA
Ser83RVal, contained additional substitutions at position 112,
127, 128 and 154. So far, these four substitutions have been found
in a Raoultella planticola and a Klebsiella oxytoca isolate (except for
position 154), as shown by sequence alignments using the NCBI
BLASTP program (accession-numbers: BAN58234.1 and
CAQ76691.1). Hitherto, very few studies have focused upon the
role of amino acid substitutions outside the QRDR [22], hence
little is known about their effect on resistance levels. Our finding
suggests that in addition to the standard QRDR, additional sites in
GyrA seem to play a role in FQ resistance. Further studies thus
need to be conducted in order to further characterize the role of
rare substituions in GyrA.
In clinical E. coli isolates, quinolone resistance is mainly
associated with mutations in gyrA whereas mutations in the
topoisomerase IV genes, parC and parE, play a secondary role [2].
To date, mutations within parC and parE are always linked to
mutations in gyrA, and it is supposed that mutations within these
genes only occur if the strain already posses a reduced sensitivity to
fluoroquinolones by mutations in DNA gyrase. Therefore,
additional mutations in parC and parE are supposed to play an
important role in the formation of highly resistant strains [2,23].
As many as 71% of the isolates described in this study, in addition
to showing one to two substitutions in GyrA, harbored substitu-
tions in ParC. Interestingly, the substitutions in ParC were found
predominantly at position Ser80, which, apart from substitutions
in GyrA, is one of the most common alterations in FQ-resistant
clinical isolates [24]. This finding is suggestive of the anthropo-
genic origin of these strains that were isolated from the aquatic
environment.
PMQR is a phenomenon of increasing importance. The most
relevant PMQR genes known to date are the acetyltransferase
gene aac(69)-Ib-cr, the qnr-like genes and genes encoding efflux
pumps, such as qepA [25,26].
In the isolates described in this study, PMQR determinant
aac(69)-Ib-cr was the most prevalent (36%), followed by qnrS1 (10%)
and qepA (2%). The relatively high prevalence of aac(69)-Ib-cr is not
surprising since several reports showed that this gene is often
present on the same plasmid as blaESBL [27,28]. QnrS-producing
strains were frequently described in aquatic environments, and - as
shown by a study by Cattoir and Co-workers [29] - Vibrio splendidus,
an aquatic Gram-negative bacteria, was identified as a possible
source for qnrS-like genes. Interestingly, in a previous study by
Pica˜o et al. [30], a qnrS2 bearing Aeromonas allosaccharophila strain
was isolated from Lake Lugano in the southern part of
Switzerland. QnrS is found very rarely and only sporadically in
clinical isolates in Europe [31]. Further, Liassine et al. [32]
investigated human ESBL-producing Enterobacteriacae isolates for
qnrA, qnrB and qnrS collected by a Swiss clinical microbiology
laboratory. However, from 155 analyzed isolates, they found only
qnrB4 (3 Citrobacter freundii, 1 Klebsiella pneumonia and 1 E. coli) and
qnrB2 (1 E. coli). In contrast to our data, no qnrS variants were
found in that study, indicating that qnrS is not characteristic for
FQ-resistant human isolates in Switzerland.
Our conjugation experiments revealed that qnrS1, and aac-69-Ib-
cr harboring plasmids were transferable to FQ-susceptible strains.
The resistance phenotypes of the resulting transconjugants
confirmed previous observations that the contribution of PMQR
Table 3. Plasmid-mediated quinolone resistance mechanisms, replicon types of transferred plasmids and quinolone resistance
levels of the transconjugants of selected E. coli isolates.
Strain Transferred gene Replicon types Etest MIC (mg/mL) [Fold-MIC increase vs. donor]
NA CIP
E. coli HK225 StrepRRifR – 4 0.023
TC_OW54E2 qnrS1 F 12 [3] 0.38 [16]
TC_ OW95E1 qnrS1 F 8 [2] 0.25 [10]
TC_OW8C2 aac-69-Ib-cr F 4 [1] 0.094 [4]
TC_OW29E1 aac-69-Ib-cr F 6 [1.5] 0.094 [4]
TC_OW77E1 aac-69-Ib-cr F 4 [1] 0.094 [4]
E. coli HK225 StrepRRifR, recipient strain resistant to streptomycin and rifamycin.
TC_OW54E2, transconjugant receiving the plasmid from the donor strain OW54E2.
doi:10.1371/journal.pone.0095864.t003
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determinants to fluoroquinolone resistance levels of the plasmid-
bearing strains is minor compared with the chromosomal
mutations in DNA gyrase. The proposed role of these genes is
that they enhance resistance to fluoroquinolones, supplementing
chromosomal resistance genes [33]. Poor transfer of qnrS-encoding
plasmids is confirmative of a previous study describing a qnrS-
harboring clinical E. coli isolate [31]. Nevertheless, our results
demonstrate that qnrS determinants are indeed transferable and
capable of conferring very low level resistance, also in the absence
of chromosomally-encoded (F)Q-resistance determinants.
Replicon typing of the transconjugants revealed that both qnrS1
and aac-69-Ib-cr are present on IncF plasmids. Additionally, the
genes coding for ESBL were detected on the same plasmids. CTX-
M-15, the most prevalent CTX-M-type isolated from water bodies
in Switzerland, is often associated with aac(69)-Ib-cr resistance
genes and has been located frequently on IncF group plasmids
[34]. IncF type plasmids carrying CTX-M-15 are an inhomoge-
neous group of plasmids with sizes that vary between 50–200 kb
and often carry more than one replicon (e.g., repFII, repFIA and/
or repFIB) [34]. This multi-replicon plasmid-genotype was also
observed in our study.
Besides chromosomal mutations and PMQR determinants,
efflux pumps can also contribute in a more unspecific way to the
(F)Q resistance phenotype. The effect of members of the
resistance-nodulation-division (RND) family of membrane trans-
porters can be investigated by inhibiting them with PAbN [35,36].
In this study, the MICs of NA decreased 4 to 32-fold in the
presence of the inhibitor, which clearly confirmed that these efflux
pumps play an important role in quinolone resistance. Sa´enz et al.
[36] could already show that a single amino acid exchange in
GyrA was not enough to confer a high level NA resistance
phenotype in E. coli.
Recently, Sato et al. [37] investigated an E. coli isolate whose
MICs of CIP, levofloxacin and norfloxacin exceeded the respective
CLSI breakpoints, although it had no mutations in the QRDRs of
either DNA gyrase or topoisomerase. The conclusion of their
study was that FQ resistance can also arise due to concomitant
acquisition of several PMQR determinates (in their study: QnrS1
and OqxAB, in combination with overexpression of acrAB-TolC
and other chromosome-encoded efflux pumps). Our study yielded
no isolate of this kind.
In summary, the acquisition of a high-level (F)Q resistance
phenotype often includes combination of multiple mechanisms
such as acquisition of mutations in DNA gyrase and topoisomerase
genes as well as enhanced efflux and these processes can be
accelerated by the presence of PMQR-determinants [2]. Our
findings suggest that this holds true also for our FQ-resistant
strains isolated from the aquatic environment.
It is possible that as a consequence of excretion of unmetab-
olized quinolones into wastewater by humans and animals, the
environmental quinolone accumulation has contributed to the
high prevalence of quinolone resistant E. coli in the water
environment [9,38].
This study provides further evidence for the importance of the
water-related environment as a reservoir for this emerging threat
of FQ resistance. Moreover, the resistance characteristics of the
isolates described in this study indicate that multilateral exchange
of genetic material between bacteria of both anthropogenic and
environmental origins is currently occurring and presents a
phenomenon of growing importance. It is, finally, worrisome that
more than two thirds of ESBL producers carry resistance
determinants against (F)Qs, thus defying the two currently most
popular antibiotic options for human therapy, b-lactams and FQs.
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